Meng-Meng Song

Dr. Meng-Meng Song


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MSMeng-Meng Song
Meng-Meng Song
HXHuai-Liang Xu
Huai-Liang Xu
JLJun-Xing Liang
Jun-Xing Liang
HXHui-Hui Xiang
Hui-Hui Xiang
RLRui Liu
Rui Liu
YSYuxian Shen
Yuxian Shen

Verified
Journal Article
Open access
PDF file
XWXian-Yun Wang
Xian-Yun Wang
MSMeng-Meng Song
Meng-Meng Song
SBSi-Xing Bi
Si-Xing Bi
YSYu-Jun Shen
Yu-Jun Shen
YSYuxian Shen
Yuxian Shen
YYYongqiang Yu
Yongqiang Yu
As an endoplasmic reticulum (ER) stress-inducible protein, mesencephalic astrocyte-derived neurotrophic factor (MANF) has been proven to protect dopaminergic neurons and nondopaminergic cells. Our previous studies had shown that MANF protected against ischemia/reperfusion injury. Here, we developed a magnetic resonance imaging (MRI) technology to dynamically evaluate the therapeutic effects of MANF on ischemia/reperfusion injury. We established a rat focal ischemic model by using middle cerebral artery occlusion (MCAO). MRI was performed to investigate the dynamics of lesion formation. MANF protein was injected into the right lateral ventricle at 3 h after reperfusion following MCAO for 90 min, when the obvious lesion firstly appeared according to MRI investigation. T2-weighted imaging for evaluating the therapeutic effects of MANF protein was performed in ischemia/reperfusion injury rats on Days 1, 2, 3, 5, and 7 post-reperfusion combined with histology methods. The results indicated that the administration of MANF protein at the early stage after ischemia/reperfusion injury decreased the mortality, improved the neurological function, reduced the cerebral infarct volume, and alleviated the brain tissue injury. The findings collected from MRI are consistent with the morphological and pathological changes, which suggest that MRI is a useful technology for evaluating the therapeutic effects of drugs.

31 January 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
MFMeng-Yu Fei
Meng-Yu Fei
MSMeng-Meng Song
Meng-Meng Song
PWPei Wang
Pei Wang
GPGao-Zong Pang
Gao-Zong Pang
JCJing Chen
Jing Chen
YYYongqiang Yu
Yongqiang Yu
Water-soluble Fe3O4@F127@FA nanoclusters were prepared by a facile ultrasonic-treated method for MR imaging and targeted drug delivery.

12 May 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
HXHui-Hui Xiang
Hui-Hui Xiang
ZZZu-Zhi Zhao
Zu-Zhi Zhao
YWYun-Kai Wu
Yun-Kai Wu
MFMeng-Yu Fei
Meng-Yu Fei
MSMeng-Meng Song
Meng-Meng Song
An ultra-sensitive T 2 -weighted MR imaging contrast agent was prepared based on Fe 3 O 4 nanoparticles and Gd 3+ ions (Fe 3 O 4 @Gd).

4 May 2022 in Nanomedicine
Verified
Journal Article
Closed access
MSMeng-Meng Song
Meng-Meng Song
JCJing Chen
Jing Chen
SYShu-Ming Ye
Shu-Ming Ye
DLDa-Peng Lu
Da-Peng Lu
GZGui-Yang Zhang
Gui-Yang Zhang
YSYuxian Shen
Yuxian Shen
Aim: To construct an edaravone-encapsulated liposomes (EDV-LIPs) formulation against acute ischemic stroke. Methods: EDV-LIPs were prepared by the film dispersion method. The biosafety was evaluate...

5 December 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
MSMeng-Meng Song
Meng-Meng Song
HXHui-Hui Xiang
Hui-Hui Xiang
MFMeng-Yu Fei
Meng-Yu Fei
DLDa-Peng Lu
Da-Peng Lu
TJTong-Cui Jiang
Tong-Cui Jiang
YSYuxian Shen
Yuxian Shen
Water-dispersible, stable and biocompatible dandelion-like Fe 3 O 4 /HBC@F127 nanocomposites were facilely developed for dual mode imaging (fluorescent/MR) and drug delivery.